Human CD29+/CD56+ myogenic progenitors display tenogenic differentiation potential and facilitate tendon regeneration
eLife · 2025
DOI: 10.7554/elife.98636 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2025. Verfasst von Xiexiang Shao und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Cell Differentiation, Regeneration, Tendons, CD56 Antigen. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Strategic Priority Research Program of the Chinese Academy of Science.
Abstract (Originalsprache)
Tendon injury occurs at high frequency and is difficult to repair. Identification of human stem cells being able to regenerate tendon will greatly facilitate the development of regenerative medicine for tendon injury. Genetic and functional analyses identify human CD29+/CD56+ myogenic progenitors with tenogenic differentiation potential in vitro and in vivo. Transplantation of human CD29+/CD56+ myogenic progenitors contributes to injured tendon repair and thus improves locomotor function. Interestingly, the tendon differentiation potential in mouse muscle stem cells is minimal and the higher TGFβ signaling level may be the key for the distinct feature of human CD29+/CD56+ myogenic progenitors. The discovery of bi-potential CD29+/CD56+ myogenic progenitors highlights their potential as a novel adult stem cell source for tendon regeneration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedic Surgery, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Sports Medicine, Peking University Third Hospital, Institute of Sports Medicine of Peking University, Beijing Key Laboratory of Sports Injuries, Beijing, China.
- Department of Bioinformatics, Fujian Key Laboratory of Medical Bioinformatics. School of Medical Technology and Engineering. Fujian Medical University, Fuzhou, China.
- State Key Laboratory of Cell Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, China.
- Department of Orthopedic Surgery, Wuhan Third Hospital, Tongren Hospital of Wuhan University, Wuhan, China.
- Guangzhou Laboratory, Guangzhou, China.
ORCID-Profile: Xiexiang Shao, Xingzuan Lin, Jianhua Wang
Förderung
- National Natural Science Foundation of China
- Strategic Priority Research Program of the Chinese Academy of Science
Zitieren
APA
Shao, X., Lin, X., Zhou, H., Wang, M., Han, L., Fu, X., Li, S., Zhu, S., Zhou, S., Yang, W., Wang, J., Li, Z., & Hu, P. (2025). Human CD29+/CD56+ myogenic progenitors display tenogenic differentiation potential and facilitate tendon regeneration. eLife. https://doi.org/10.7554/elife.98636
Vancouver
Shao X, Lin X, Zhou H, Wang M, Han L, Fu X, et al. Human CD29+/CD56+ myogenic progenitors display tenogenic differentiation potential and facilitate tendon regeneration. eLife. 2025. doi:10.7554/elife.98636
BibTeX
@article{Shao2025,
author = {Shao, Xiexiang and Lin, Xingzuan and Zhou, Hao and Wang, Minghui and Han, Lili and Fu, Xin and Li, Sheng and Zhu, Siyuan and Zhou, Shenao and Yang, Wenjun and Wang, Jianhua and Li, Zhanghua and Hu, Ping},
title = {Human CD29+/CD56+ myogenic progenitors display tenogenic differentiation potential and facilitate tendon regeneration},
journal = {eLife},
year = {2025},
doi = {10.7554/elife.98636}
}
EUVIMED